303 related articles for article (PubMed ID: 33328987)
1. Da-Chai-Hu Decoction Ameliorates High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Through Remodeling the Gut Microbiota and Modulating the Serum Metabolism.
Cui H; Li Y; Wang Y; Jin L; Yang L; Wang L; Liao J; Wang H; Peng Y; Zhang Z; Wang H; Liu X
Front Pharmacol; 2020; 11():584090. PubMed ID: 33328987
[TBL] [Abstract][Full Text] [Related]
2. Er-Chen Decoction Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Rats through Remodeling Gut Microbiota and Regulating the Serum Metabolism.
Miao J; Guo L; Cui H; Wang L; Zhu B; Lei J; Li P; Jia J; Zhang Z
Evid Based Complement Alternat Med; 2022; 2022():6221340. PubMed ID: 35399623
[TBL] [Abstract][Full Text] [Related]
3. Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses.
Wang S; Li X; Zhang B; Li Y; Chen K; Qi H; Gao M; Rong J; Liu L; Wan Y; Dong X; Yan M; Ma L; Li P; Zhao T
Biomed Pharmacother; 2024 Apr; 173():116405. PubMed ID: 38484559
[TBL] [Abstract][Full Text] [Related]
4. Yinchen Linggui Zhugan decoction ameliorates high fat diet-induced nonalcoholic fatty liver disease by modulation of SIRT1/Nrf2 signaling pathway and gut microbiota.
Jiang H; Mao T; Sun Z; Shi L; Han X; Zhang Y; Zhang X; Wang J; Hu J; Zhang L; Li J; Han H
Front Microbiol; 2022; 13():1001778. PubMed ID: 36578580
[TBL] [Abstract][Full Text] [Related]
5. Terminalia bellirica ethanol extract ameliorates nonalcoholic fatty liver disease in mice by amending the intestinal microbiota and faecal metabolites.
Zhang B; Luo X; Han C; Liu J; Zhang L; Qi J; Gu J; Tan R; Gong P
J Ethnopharmacol; 2023 Apr; 305():116082. PubMed ID: 36581163
[TBL] [Abstract][Full Text] [Related]
6. Pi-Dan-Jian-Qing Decoction Ameliorates Type 2 Diabetes Mellitus Through Regulating the Gut Microbiota and Serum Metabolism.
Xie X; Liao J; Ai Y; Gao J; Zhao J; Qu F; Xu C; Zhang Z; Wen W; Cui H; Wang H
Front Cell Infect Microbiol; 2021; 11():748872. PubMed ID: 34938667
[TBL] [Abstract][Full Text] [Related]
7. Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids.
Ni Y; Wang X; Wu Q; Yao Y; Xu Y; Li Y; Feng Q; Zhou M; Gou X
Front Endocrinol (Lausanne); 2023; 14():1272214. PubMed ID: 37900123
[TBL] [Abstract][Full Text] [Related]
8. Dachaihu decoction ameliorates septic intestinal injury via modulating the gut microbiota and glutathione metabolism as revealed by multi-omics.
Huang N; Wei Y; Liu M; Yang Z; Yuan K; Chen J; Wu Z; Zheng F; Lei K; He M
J Ethnopharmacol; 2023 Aug; 312():116505. PubMed ID: 37080366
[TBL] [Abstract][Full Text] [Related]
9. Nobiletin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Gut Microbiota and Myristoleic Acid Metabolism.
Li SZ; Zhang NN; Yang X; Huang TQ; Lin Y; Jiang ZM; Yi Y; Liu EH
J Agric Food Chem; 2023 May; 71(19):7312-7323. PubMed ID: 37139957
[TBL] [Abstract][Full Text] [Related]
10. Noni (Morinda citrifolia L.) fruit phenolic extract supplementation ameliorates NAFLD by modulating insulin resistance, oxidative stress, inflammation, liver metabolism and gut microbiota.
Wang R; Wang L; Wu H; Zhang L; Hu X; Li C; Liu S
Food Res Int; 2022 Oct; 160():111732. PubMed ID: 36076420
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
12. Hepatoprotective Effects of
Jin W; Cho S; Laxi N; Bao T; Dai L; Yu H; Qi R; Zhang J; Ba G; Fu M
Molecules; 2022 May; 27(10):. PubMed ID: 35630624
[No Abstract] [Full Text] [Related]
13. Perilla Oil Has Similar Protective Effects of Fish Oil on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Gut Dysbiosis.
Tian Y; Wang H; Yuan F; Li N; Huang Q; He L; Wang L; Liu Z
Biomed Res Int; 2016; 2016():9462571. PubMed ID: 27051672
[TBL] [Abstract][Full Text] [Related]
14. Jian-Gan-Xiao-Zhi Decoction Alleviates Inflammatory Response in Nonalcoholic Fatty Liver Disease Model Rats through Modulating Gut Microbiota.
Liao J; Xie X; Gao J; Zhang Z; Qu F; Cui H; Cao Y; Han X; Zhao J; Wen W; Wang H
Evid Based Complement Alternat Med; 2021; 2021():5522755. PubMed ID: 33824675
[TBL] [Abstract][Full Text] [Related]
15. Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation.
Zhao Z; Chen L; Zhao Y; Wang C; Duan C; Yang G; Niu C; Li S
Appl Microbiol Biotechnol; 2020 Jun; 104(12):5273-5282. PubMed ID: 32335723
[TBL] [Abstract][Full Text] [Related]
16. SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis.
Chen M; Hui S; Lang H; Zhou M; Zhang Y; Kang C; Zeng X; Zhang Q; Yi L; Mi M
Mol Nutr Food Res; 2019 Feb; 63(4):e1800612. PubMed ID: 30525304
[TBL] [Abstract][Full Text] [Related]
17. Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism.
Zhang L; Xie C; Nichols RG; Chan SH; Jiang C; Hao R; Smith PB; Cai J; Simons MN; Hatzakis E; Maranas CD; Gonzalez FJ; Patterson AD
mSystems; 2016; 1(5):. PubMed ID: 27822554
[TBL] [Abstract][Full Text] [Related]
18. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
Shen SH; Zhong TY; Peng C; Fang J; Lv B
BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
[TBL] [Abstract][Full Text] [Related]
19. Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites.
Chen D; Wang Y; Yang J; Ou W; Lin G; Zeng Z; Lu X; Chen Z; Zou L; Tian Y; Wu A; Keating SE; Yang Q; Lin C; Liang Y
Front Pharmacol; 2024; 15():1343755. PubMed ID: 38720776
[No Abstract] [Full Text] [Related]
20. San-Huang-Yi-Shen Capsule Ameliorates Diabetic Nephropathy in Rats Through Modulating the Gut Microbiota and Overall Metabolism.
Su X; Yu W; Liu A; Wang C; Li X; Gao J; Liu X; Jiang W; Yang Y; Lv S
Front Pharmacol; 2021; 12():808867. PubMed ID: 35058786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
